Waldron Private Wealth’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1
| Closed | -$57K | – | 375 |
|
|
2021
Q2 | $57K | Hold |
1
| – | – | ﹤0.01% | 332 |
|
|
2021
Q1 | $93K | Hold |
1
| – | – | 0.01% | 301 |
|
|
2020
Q4 | $67K | Hold |
1
| – | – | 0.01% | 286 |
|
|
2020
Q3 | $49K | Hold |
1
| – | – | ﹤0.01% | 269 |
|
|
2020
Q2 | $63K | Hold |
1
| – | – | 0.01% | 253 |
|
|
2020
Q1 | $40K | Hold |
1
| – | – | ﹤0.01% | 232 |
|
|
2019
Q4 | $72K | Hold |
1
| – | – | 0.01% | 269 |
|
|
2019
Q3 | $41K | Hold |
1
| – | – | ﹤0.01% | 251 |
|
|
2019
Q2 | $118K | Hold |
1
| – | – | 0.01% | 237 |
|
|
2019
Q1 | $169K | Buy |
+1
| New | +$169K | 0.02% | 248 |
|